Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Sep 13, 2021 12:35pm
375 Views
Post# 33848884

RE:RE:RE:RE:RE:The Dilemma

RE:RE:RE:RE:RE:The DilemmaWith both patients 19 & 20 reaching their 90 day points and IF one or both have CR that bodes well on the data as it pushes the success percentage higher. We've seen this recent newsletter extremely late but generally newsletters are released roughly 4 to 6 weeks after the actual quarterly date so the 3rd quarter ends Sept. 30/21 that would put the upcoming newsletter between Oct 27th to Nov 12/21. We know that both 19 & 20 with CR will show this TLD-1433 treatment works and to expect continued higher net results on all new enrolled patients. 
Theralase has the same maggot eating at its share price as the mining stocks have suffered which is the predatory shorting, how many shareholders have added their names to the list against predatory shorting by signing the petition is low although many complain few people go that one step further. 

www.savecanadianmining.com





Oden6570 wrote
Thanks Let us hope the sp rises on results and another warrant extension is avoided
.
Pandora wrote:
Oden, we have 37.5 cent warrants coming due on November 10, 2021 i.e. less than two months.

Rumpl3StiltSkin wrote:
enriquesuave wrote:

Hopefully next data readouts will show a clear picture of what TLD-1433 PDT can achieve and the market will take us way about warrants strike price.  Warrants excercised would bring close to $7 million.  Enough for the whole trial and more.  If BTD comes in and AA is again on the table then definitely no worries  All IMO

 

Johnandrose22 wrote: Perhaps the company’s equity price is indicative of a dilemma that long term share holders have experienced all too often. The company has indicated that the current phase 2 trial could last until 2024-2025. Despite its insistence, the company’s financial coffers do not necessarily equate to those stated target dates. 

Thus...the dilemma...where will the money be generated to accomplish the company’s goals? It seems the market is telling us another PP is probably more realistic than a JV or even a buyout.

And so it is...I never thought I’d be thinking this (or even writing it) when I first invested in 2014.

John
 

 

 



The warrants due in three years won't help us in time. Firing Shawn, or maybe he quit, will save a good amount of salary and perhaps extend the $$ out a lil bit more. I believe a year from now, do we have that long?, the picture will be very clear. Yes BTD and AA will certainly help attract partners/suitors. :-) Don't forget the Covid 19 angle, that could attract some steep llicense fees and royaltees for TLT.
 

 




<< Previous
Bullboard Posts
Next >>